nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CYP1A2—Flutamide—prostate cancer	0.0963	0.347	CbGbCtD
Atropine—CYP1A2—Estrone—prostate cancer	0.0696	0.251	CbGbCtD
Atropine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0456	0.164	CbGbCtD
Atropine—CYP1A2—Estradiol—prostate cancer	0.04	0.144	CbGbCtD
Atropine—CHRM3—ureter—prostate cancer	0.03	0.459	CbGeAlD
Atropine—CYP1A2—Etoposide—prostate cancer	0.0261	0.0941	CbGbCtD
Atropine—CYP1A2—urine—prostate cancer	0.00739	0.113	CbGeAlD
Atropine—CHRM5—epithelium—prostate cancer	0.00459	0.0704	CbGeAlD
Atropine—CHRM2—prostate gland—prostate cancer	0.00429	0.0658	CbGeAlD
Atropine—CHRM1—prostate gland—prostate cancer	0.00391	0.0599	CbGeAlD
Atropine—CHRM4—testis—prostate cancer	0.00352	0.054	CbGeAlD
Atropine—CHRM3—prostate gland—prostate cancer	0.00349	0.0536	CbGeAlD
Atropine—CHRM3—renal system—prostate cancer	0.00238	0.0365	CbGeAlD
Atropine—CHRM3—urethra—prostate cancer	0.00234	0.0359	CbGeAlD
Atropine—Granisetron—CYP3A5—prostate cancer	0.00211	0.271	CrCbGaD
Atropine—CYP1A2—renal system—prostate cancer	0.00181	0.0277	CbGeAlD
Atropine—CHRM3—testis—prostate cancer	0.00154	0.0236	CbGeAlD
Atropine—Granisetron—CYP1A1—prostate cancer	0.00143	0.183	CrCbGaD
Atropine—Cocaine—CYP3A5—prostate cancer	0.001	0.129	CrCbGaD
Atropine—Dolasetron—CYP3A4—prostate cancer	0.000999	0.128	CrCbGaD
Atropine—Granisetron—CYP3A4—prostate cancer	0.000914	0.117	CrCbGaD
Atropine—Benzatropine—CYP2C19—prostate cancer	0.000512	0.0656	CrCbGaD
Atropine—Cocaine—CYP3A4—prostate cancer	0.000435	0.0557	CrCbGaD
Atropine—Ipratropium bromide—CYP3A4—prostate cancer	0.000398	0.051	CrCbGaD
Atropine—Body temperature increased—Mitoxantrone—prostate cancer	0.000195	0.000431	CcSEcCtD
Atropine—Flushing—Prednisone—prostate cancer	0.000192	0.000425	CcSEcCtD
Atropine—Hypotension—Etoposide—prostate cancer	0.000192	0.000424	CcSEcCtD
Atropine—Vision blurred—Capecitabine—prostate cancer	0.00019	0.000422	CcSEcCtD
Atropine—Asthenia—Estradiol—prostate cancer	0.00019	0.00042	CcSEcCtD
Atropine—Dysuria—Epirubicin—prostate cancer	0.000189	0.000418	CcSEcCtD
Atropine—Abdominal distension—Doxorubicin—prostate cancer	0.000188	0.000417	CcSEcCtD
Atropine—Syncope—Docetaxel—prostate cancer	0.000187	0.000414	CcSEcCtD
Atropine—Pruritus—Estradiol—prostate cancer	0.000187	0.000414	CcSEcCtD
Atropine—Dysphagia—Doxorubicin—prostate cancer	0.000187	0.000414	CcSEcCtD
Atropine—Arrhythmia—Prednisone—prostate cancer	0.000185	0.000409	CcSEcCtD
Atropine—Palpitations—Docetaxel—prostate cancer	0.000184	0.000408	CcSEcCtD
Atropine—Loss of consciousness—Docetaxel—prostate cancer	0.000183	0.000406	CcSEcCtD
Atropine—Dyspnoea—Etoposide—prostate cancer	0.000183	0.000405	CcSEcCtD
Atropine—Hyperglycaemia—Epirubicin—prostate cancer	0.000182	0.000403	CcSEcCtD
Atropine—Somnolence—Etoposide—prostate cancer	0.000182	0.000403	CcSEcCtD
Atropine—Angina pectoris—Doxorubicin—prostate cancer	0.000182	0.000403	CcSEcCtD
Atropine—Vertigo—Capecitabine—prostate cancer	0.000182	0.000402	CcSEcCtD
Atropine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000182	0.000402	CcSEcCtD
Atropine—Syncope—Capecitabine—prostate cancer	0.000181	0.000401	CcSEcCtD
Atropine—Mental disorder—Prednisone—prostate cancer	0.000181	0.000401	CcSEcCtD
Atropine—Diarrhoea—Estradiol—prostate cancer	0.000181	0.000401	CcSEcCtD
Atropine—Convulsion—Docetaxel—prostate cancer	0.000181	0.0004	CcSEcCtD
Atropine—Drowsiness—Epirubicin—prostate cancer	0.00018	0.000399	CcSEcCtD
Atropine—Erythema—Prednisone—prostate cancer	0.00018	0.000398	CcSEcCtD
Atropine—Palpitations—Capecitabine—prostate cancer	0.000179	0.000395	CcSEcCtD
Atropine—Chest pain—Docetaxel—prostate cancer	0.000178	0.000393	CcSEcCtD
Atropine—Loss of consciousness—Capecitabine—prostate cancer	0.000178	0.000393	CcSEcCtD
Atropine—Asthenia—Mitoxantrone—prostate cancer	0.000177	0.000391	CcSEcCtD
Atropine—Fatigue—Etoposide—prostate cancer	0.000177	0.000391	CcSEcCtD
Atropine—Pain—Etoposide—prostate cancer	0.000175	0.000388	CcSEcCtD
Atropine—Constipation—Etoposide—prostate cancer	0.000175	0.000388	CcSEcCtD
Atropine—Conjunctivitis—Epirubicin—prostate cancer	0.000175	0.000388	CcSEcCtD
Atropine—Dizziness—Estradiol—prostate cancer	0.000175	0.000387	CcSEcCtD
Atropine—Dysuria—Doxorubicin—prostate cancer	0.000175	0.000387	CcSEcCtD
Atropine—Dry mouth—Docetaxel—prostate cancer	0.000174	0.000385	CcSEcCtD
Atropine—Sweating—Epirubicin—prostate cancer	0.000173	0.000382	CcSEcCtD
Atropine—Chest pain—Capecitabine—prostate cancer	0.000172	0.000381	CcSEcCtD
Atropine—Confusional state—Docetaxel—prostate cancer	0.000172	0.00038	CcSEcCtD
Atropine—Anxiety—Capecitabine—prostate cancer	0.000171	0.00038	CcSEcCtD
Atropine—Anaphylactic shock—Docetaxel—prostate cancer	0.00017	0.000377	CcSEcCtD
Atropine—Oedema—Docetaxel—prostate cancer	0.00017	0.000377	CcSEcCtD
Atropine—Vision blurred—Prednisone—prostate cancer	0.00017	0.000376	CcSEcCtD
Atropine—Feeling abnormal—Etoposide—prostate cancer	0.000169	0.000374	CcSEcCtD
Atropine—Hyperglycaemia—Doxorubicin—prostate cancer	0.000169	0.000373	CcSEcCtD
Atropine—Diarrhoea—Mitoxantrone—prostate cancer	0.000169	0.000373	CcSEcCtD
Atropine—Dry mouth—Capecitabine—prostate cancer	0.000168	0.000372	CcSEcCtD
Atropine—Vomiting—Estradiol—prostate cancer	0.000168	0.000372	CcSEcCtD
Atropine—Gastrointestinal pain—Etoposide—prostate cancer	0.000168	0.000371	CcSEcCtD
Atropine—Shock—Docetaxel—prostate cancer	0.000168	0.000371	CcSEcCtD
Atropine—Rash—Estradiol—prostate cancer	0.000167	0.000369	CcSEcCtD
Atropine—Drowsiness—Doxorubicin—prostate cancer	0.000167	0.000369	CcSEcCtD
Atropine—Dermatitis—Estradiol—prostate cancer	0.000167	0.000369	CcSEcCtD
Atropine—Confusional state—Capecitabine—prostate cancer	0.000166	0.000368	CcSEcCtD
Atropine—Tachycardia—Docetaxel—prostate cancer	0.000166	0.000368	CcSEcCtD
Atropine—Headache—Estradiol—prostate cancer	0.000166	0.000367	CcSEcCtD
Atropine—Agitation—Prednisone—prostate cancer	0.000165	0.000366	CcSEcCtD
Atropine—Oedema—Capecitabine—prostate cancer	0.000165	0.000365	CcSEcCtD
Atropine—Bradycardia—Epirubicin—prostate cancer	0.000165	0.000364	CcSEcCtD
Atropine—Angioedema—Prednisone—prostate cancer	0.000164	0.000364	CcSEcCtD
Atropine—Urticaria—Etoposide—prostate cancer	0.000163	0.00036	CcSEcCtD
Atropine—Shock—Capecitabine—prostate cancer	0.000162	0.000359	CcSEcCtD
Atropine—Abdominal pain—Etoposide—prostate cancer	0.000162	0.000359	CcSEcCtD
Atropine—Body temperature increased—Etoposide—prostate cancer	0.000162	0.000359	CcSEcCtD
Atropine—Conjunctivitis—Doxorubicin—prostate cancer	0.000162	0.000359	CcSEcCtD
Atropine—Vertigo—Prednisone—prostate cancer	0.000162	0.000358	CcSEcCtD
Atropine—Syncope—Prednisone—prostate cancer	0.000161	0.000357	CcSEcCtD
Atropine—Tachycardia—Capecitabine—prostate cancer	0.000161	0.000356	CcSEcCtD
Atropine—Sweating—Doxorubicin—prostate cancer	0.00016	0.000354	CcSEcCtD
Atropine—Hyperhidrosis—Capecitabine—prostate cancer	0.000159	0.000353	CcSEcCtD
Atropine—Hypotension—Docetaxel—prostate cancer	0.000159	0.000352	CcSEcCtD
Atropine—Loss of consciousness—Prednisone—prostate cancer	0.000158	0.00035	CcSEcCtD
Atropine—Nausea—Estradiol—prostate cancer	0.000157	0.000348	CcSEcCtD
Atropine—Vomiting—Mitoxantrone—prostate cancer	0.000157	0.000347	CcSEcCtD
Atropine—Convulsion—Prednisone—prostate cancer	0.000156	0.000345	CcSEcCtD
Atropine—Rash—Mitoxantrone—prostate cancer	0.000155	0.000344	CcSEcCtD
Atropine—Dermatitis—Mitoxantrone—prostate cancer	0.000155	0.000344	CcSEcCtD
Atropine—Headache—Mitoxantrone—prostate cancer	0.000154	0.000342	CcSEcCtD
Atropine—Hypotension—Capecitabine—prostate cancer	0.000154	0.000341	CcSEcCtD
Atropine—Insomnia—Docetaxel—prostate cancer	0.000154	0.000341	CcSEcCtD
Atropine—Anxiety—Prednisone—prostate cancer	0.000153	0.000338	CcSEcCtD
Atropine—Bradycardia—Doxorubicin—prostate cancer	0.000152	0.000337	CcSEcCtD
Atropine—Dyspnoea—Docetaxel—prostate cancer	0.000152	0.000336	CcSEcCtD
Atropine—Somnolence—Docetaxel—prostate cancer	0.000151	0.000335	CcSEcCtD
Atropine—Hypersensitivity—Etoposide—prostate cancer	0.000151	0.000334	CcSEcCtD
Atropine—Flushing—Epirubicin—prostate cancer	0.00015	0.000332	CcSEcCtD
Atropine—Dyspepsia—Docetaxel—prostate cancer	0.00015	0.000332	CcSEcCtD
Atropine—Insomnia—Capecitabine—prostate cancer	0.000149	0.00033	CcSEcCtD
Atropine—Asthenia—Etoposide—prostate cancer	0.000147	0.000326	CcSEcCtD
Atropine—Dyspnoea—Capecitabine—prostate cancer	0.000147	0.000326	CcSEcCtD
Atropine—Oedema—Prednisone—prostate cancer	0.000147	0.000325	CcSEcCtD
Atropine—Anaphylactic shock—Prednisone—prostate cancer	0.000147	0.000325	CcSEcCtD
Atropine—Fatigue—Docetaxel—prostate cancer	0.000147	0.000325	CcSEcCtD
Atropine—Nausea—Mitoxantrone—prostate cancer	0.000146	0.000324	CcSEcCtD
Atropine—Pain—Docetaxel—prostate cancer	0.000146	0.000322	CcSEcCtD
Atropine—Constipation—Docetaxel—prostate cancer	0.000146	0.000322	CcSEcCtD
Atropine—Dyspepsia—Capecitabine—prostate cancer	0.000145	0.000321	CcSEcCtD
Atropine—Pruritus—Etoposide—prostate cancer	0.000145	0.000321	CcSEcCtD
Atropine—Shock—Prednisone—prostate cancer	0.000145	0.00032	CcSEcCtD
Atropine—Arrhythmia—Epirubicin—prostate cancer	0.000144	0.00032	CcSEcCtD
Atropine—Tachycardia—Prednisone—prostate cancer	0.000143	0.000317	CcSEcCtD
Atropine—Fatigue—Capecitabine—prostate cancer	0.000142	0.000315	CcSEcCtD
Atropine—Hyperhidrosis—Prednisone—prostate cancer	0.000142	0.000314	CcSEcCtD
Atropine—Mental disorder—Epirubicin—prostate cancer	0.000142	0.000314	CcSEcCtD
Atropine—Constipation—Capecitabine—prostate cancer	0.000141	0.000312	CcSEcCtD
Atropine—Pain—Capecitabine—prostate cancer	0.000141	0.000312	CcSEcCtD
Atropine—Erythema—Epirubicin—prostate cancer	0.000141	0.000312	CcSEcCtD
Atropine—Feeling abnormal—Docetaxel—prostate cancer	0.00014	0.000311	CcSEcCtD
Atropine—Diarrhoea—Etoposide—prostate cancer	0.00014	0.00031	CcSEcCtD
Atropine—Gastrointestinal pain—Docetaxel—prostate cancer	0.000139	0.000308	CcSEcCtD
Atropine—Flushing—Doxorubicin—prostate cancer	0.000139	0.000307	CcSEcCtD
Atropine—Tension—Epirubicin—prostate cancer	0.000138	0.000306	CcSEcCtD
Atropine—Dysgeusia—Epirubicin—prostate cancer	0.000138	0.000305	CcSEcCtD
Atropine—Nervousness—Epirubicin—prostate cancer	0.000137	0.000303	CcSEcCtD
Atropine—Feeling abnormal—Capecitabine—prostate cancer	0.000136	0.000301	CcSEcCtD
Atropine—Dizziness—Etoposide—prostate cancer	0.000136	0.0003	CcSEcCtD
Atropine—Gastrointestinal pain—Capecitabine—prostate cancer	0.000135	0.000299	CcSEcCtD
Atropine—Abdominal pain—Docetaxel—prostate cancer	0.000135	0.000298	CcSEcCtD
Atropine—Body temperature increased—Docetaxel—prostate cancer	0.000135	0.000298	CcSEcCtD
Atropine—Arrhythmia—Doxorubicin—prostate cancer	0.000134	0.000296	CcSEcCtD
Atropine—Insomnia—Prednisone—prostate cancer	0.000133	0.000294	CcSEcCtD
Atropine—Vision blurred—Epirubicin—prostate cancer	0.000133	0.000294	CcSEcCtD
Atropine—Mental disorder—Doxorubicin—prostate cancer	0.000131	0.00029	CcSEcCtD
Atropine—Urticaria—Capecitabine—prostate cancer	0.000131	0.00029	CcSEcCtD
Atropine—Body temperature increased—Capecitabine—prostate cancer	0.00013	0.000289	CcSEcCtD
Atropine—Abdominal pain—Capecitabine—prostate cancer	0.00013	0.000289	CcSEcCtD
Atropine—Vomiting—Etoposide—prostate cancer	0.00013	0.000289	CcSEcCtD
Atropine—Erythema—Doxorubicin—prostate cancer	0.00013	0.000288	CcSEcCtD
Atropine—Agitation—Epirubicin—prostate cancer	0.000129	0.000286	CcSEcCtD
Atropine—Dyspepsia—Prednisone—prostate cancer	0.000129	0.000286	CcSEcCtD
Atropine—Rash—Etoposide—prostate cancer	0.000129	0.000286	CcSEcCtD
Atropine—Dermatitis—Etoposide—prostate cancer	0.000129	0.000286	CcSEcCtD
Atropine—Headache—Etoposide—prostate cancer	0.000128	0.000284	CcSEcCtD
Atropine—Tension—Doxorubicin—prostate cancer	0.000128	0.000283	CcSEcCtD
Atropine—Dysgeusia—Doxorubicin—prostate cancer	0.000128	0.000282	CcSEcCtD
Atropine—Fatigue—Prednisone—prostate cancer	0.000127	0.00028	CcSEcCtD
Atropine—Nervousness—Doxorubicin—prostate cancer	0.000127	0.00028	CcSEcCtD
Atropine—Vertigo—Epirubicin—prostate cancer	0.000126	0.00028	CcSEcCtD
Atropine—Syncope—Epirubicin—prostate cancer	0.000126	0.000279	CcSEcCtD
Atropine—Constipation—Prednisone—prostate cancer	0.000126	0.000278	CcSEcCtD
Atropine—Hypersensitivity—Docetaxel—prostate cancer	0.000126	0.000278	CcSEcCtD
Atropine—Palpitations—Epirubicin—prostate cancer	0.000124	0.000275	CcSEcCtD
Atropine—Loss of consciousness—Epirubicin—prostate cancer	0.000124	0.000274	CcSEcCtD
Atropine—Vision blurred—Doxorubicin—prostate cancer	0.000123	0.000272	CcSEcCtD
Atropine—Asthenia—Docetaxel—prostate cancer	0.000122	0.000271	CcSEcCtD
Atropine—Convulsion—Epirubicin—prostate cancer	0.000122	0.00027	CcSEcCtD
Atropine—Nausea—Etoposide—prostate cancer	0.000122	0.00027	CcSEcCtD
Atropine—Hypersensitivity—Capecitabine—prostate cancer	0.000122	0.000269	CcSEcCtD
Atropine—Feeling abnormal—Prednisone—prostate cancer	0.000121	0.000268	CcSEcCtD
Atropine—Pruritus—Docetaxel—prostate cancer	0.000121	0.000267	CcSEcCtD
Atropine—Gastrointestinal pain—Prednisone—prostate cancer	0.00012	0.000266	CcSEcCtD
Atropine—Chest pain—Epirubicin—prostate cancer	0.00012	0.000265	CcSEcCtD
Atropine—Agitation—Doxorubicin—prostate cancer	0.00012	0.000265	CcSEcCtD
Atropine—Anxiety—Epirubicin—prostate cancer	0.000119	0.000264	CcSEcCtD
Atropine—Asthenia—Capecitabine—prostate cancer	0.000118	0.000262	CcSEcCtD
Atropine—Dry mouth—Epirubicin—prostate cancer	0.000117	0.000259	CcSEcCtD
Atropine—Vertigo—Doxorubicin—prostate cancer	0.000117	0.000259	CcSEcCtD
Atropine—Syncope—Doxorubicin—prostate cancer	0.000117	0.000259	CcSEcCtD
Atropine—Urticaria—Prednisone—prostate cancer	0.000117	0.000258	CcSEcCtD
Atropine—Pruritus—Capecitabine—prostate cancer	0.000117	0.000258	CcSEcCtD
Atropine—Diarrhoea—Docetaxel—prostate cancer	0.000117	0.000258	CcSEcCtD
Atropine—Body temperature increased—Prednisone—prostate cancer	0.000116	0.000257	CcSEcCtD
Atropine—Abdominal pain—Prednisone—prostate cancer	0.000116	0.000257	CcSEcCtD
Atropine—Confusional state—Epirubicin—prostate cancer	0.000116	0.000256	CcSEcCtD
Atropine—Palpitations—Doxorubicin—prostate cancer	0.000115	0.000255	CcSEcCtD
Atropine—Anaphylactic shock—Epirubicin—prostate cancer	0.000115	0.000254	CcSEcCtD
Atropine—Oedema—Epirubicin—prostate cancer	0.000115	0.000254	CcSEcCtD
Atropine—Loss of consciousness—Doxorubicin—prostate cancer	0.000115	0.000253	CcSEcCtD
Atropine—Shock—Epirubicin—prostate cancer	0.000113	0.00025	CcSEcCtD
Atropine—Convulsion—Doxorubicin—prostate cancer	0.000113	0.00025	CcSEcCtD
Atropine—Diarrhoea—Capecitabine—prostate cancer	0.000113	0.00025	CcSEcCtD
Atropine—Dizziness—Docetaxel—prostate cancer	0.000113	0.000249	CcSEcCtD
Atropine—Tachycardia—Epirubicin—prostate cancer	0.000112	0.000248	CcSEcCtD
Atropine—Hyperhidrosis—Epirubicin—prostate cancer	0.000111	0.000246	CcSEcCtD
Atropine—Chest pain—Doxorubicin—prostate cancer	0.000111	0.000246	CcSEcCtD
Atropine—Anxiety—Doxorubicin—prostate cancer	0.000111	0.000245	CcSEcCtD
Atropine—Dizziness—Capecitabine—prostate cancer	0.000109	0.000241	CcSEcCtD
Atropine—Dry mouth—Doxorubicin—prostate cancer	0.000108	0.00024	CcSEcCtD
Atropine—Vomiting—Docetaxel—prostate cancer	0.000108	0.00024	CcSEcCtD
Atropine—Hypersensitivity—Prednisone—prostate cancer	0.000108	0.00024	CcSEcCtD
Atropine—Rash—Docetaxel—prostate cancer	0.000107	0.000238	CcSEcCtD
Atropine—Hypotension—Epirubicin—prostate cancer	0.000107	0.000238	CcSEcCtD
Atropine—Dermatitis—Docetaxel—prostate cancer	0.000107	0.000238	CcSEcCtD
Atropine—Confusional state—Doxorubicin—prostate cancer	0.000107	0.000237	CcSEcCtD
Atropine—Headache—Docetaxel—prostate cancer	0.000107	0.000236	CcSEcCtD
Atropine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000106	0.000235	CcSEcCtD
Atropine—Oedema—Doxorubicin—prostate cancer	0.000106	0.000235	CcSEcCtD
Atropine—Asthenia—Prednisone—prostate cancer	0.000105	0.000233	CcSEcCtD
Atropine—Vomiting—Capecitabine—prostate cancer	0.000105	0.000232	CcSEcCtD
Atropine—Shock—Doxorubicin—prostate cancer	0.000105	0.000232	CcSEcCtD
Atropine—Rash—Capecitabine—prostate cancer	0.000104	0.00023	CcSEcCtD
Atropine—Pruritus—Prednisone—prostate cancer	0.000104	0.00023	CcSEcCtD
Atropine—Insomnia—Epirubicin—prostate cancer	0.000104	0.00023	CcSEcCtD
Atropine—Dermatitis—Capecitabine—prostate cancer	0.000104	0.00023	CcSEcCtD
Atropine—Tachycardia—Doxorubicin—prostate cancer	0.000104	0.00023	CcSEcCtD
Atropine—Headache—Capecitabine—prostate cancer	0.000103	0.000229	CcSEcCtD
Atropine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000103	0.000228	CcSEcCtD
Atropine—Dyspnoea—Epirubicin—prostate cancer	0.000102	0.000227	CcSEcCtD
Atropine—Somnolence—Epirubicin—prostate cancer	0.000102	0.000226	CcSEcCtD
Atropine—Nausea—Docetaxel—prostate cancer	0.000101	0.000224	CcSEcCtD
Atropine—Dyspepsia—Epirubicin—prostate cancer	0.000101	0.000224	CcSEcCtD
Atropine—Diarrhoea—Prednisone—prostate cancer	0.000101	0.000223	CcSEcCtD
Atropine—Hypotension—Doxorubicin—prostate cancer	9.94e-05	0.00022	CcSEcCtD
Atropine—Fatigue—Epirubicin—prostate cancer	9.91e-05	0.000219	CcSEcCtD
Atropine—Constipation—Epirubicin—prostate cancer	9.83e-05	0.000218	CcSEcCtD
Atropine—Pain—Epirubicin—prostate cancer	9.83e-05	0.000218	CcSEcCtD
Atropine—Nausea—Capecitabine—prostate cancer	9.8e-05	0.000217	CcSEcCtD
Atropine—Dizziness—Prednisone—prostate cancer	9.72e-05	0.000215	CcSEcCtD
Atropine—Insomnia—Doxorubicin—prostate cancer	9.62e-05	0.000213	CcSEcCtD
Atropine—Dyspnoea—Doxorubicin—prostate cancer	9.48e-05	0.00021	CcSEcCtD
Atropine—Feeling abnormal—Epirubicin—prostate cancer	9.47e-05	0.00021	CcSEcCtD
Atropine—Somnolence—Doxorubicin—prostate cancer	9.45e-05	0.000209	CcSEcCtD
Atropine—Gastrointestinal pain—Epirubicin—prostate cancer	9.4e-05	0.000208	CcSEcCtD
Atropine—Dyspepsia—Doxorubicin—prostate cancer	9.36e-05	0.000207	CcSEcCtD
Atropine—Vomiting—Prednisone—prostate cancer	9.34e-05	0.000207	CcSEcCtD
Atropine—Rash—Prednisone—prostate cancer	9.26e-05	0.000205	CcSEcCtD
Atropine—Dermatitis—Prednisone—prostate cancer	9.26e-05	0.000205	CcSEcCtD
Atropine—Headache—Prednisone—prostate cancer	9.2e-05	0.000204	CcSEcCtD
Atropine—Fatigue—Doxorubicin—prostate cancer	9.17e-05	0.000203	CcSEcCtD
Atropine—Urticaria—Epirubicin—prostate cancer	9.13e-05	0.000202	CcSEcCtD
Atropine—Pain—Doxorubicin—prostate cancer	9.09e-05	0.000201	CcSEcCtD
Atropine—Constipation—Doxorubicin—prostate cancer	9.09e-05	0.000201	CcSEcCtD
Atropine—Body temperature increased—Epirubicin—prostate cancer	9.08e-05	0.000201	CcSEcCtD
Atropine—Abdominal pain—Epirubicin—prostate cancer	9.08e-05	0.000201	CcSEcCtD
Atropine—Feeling abnormal—Doxorubicin—prostate cancer	8.76e-05	0.000194	CcSEcCtD
Atropine—Nausea—Prednisone—prostate cancer	8.73e-05	0.000193	CcSEcCtD
Atropine—Gastrointestinal pain—Doxorubicin—prostate cancer	8.69e-05	0.000192	CcSEcCtD
Atropine—Hypersensitivity—Epirubicin—prostate cancer	8.47e-05	0.000187	CcSEcCtD
Atropine—Urticaria—Doxorubicin—prostate cancer	8.45e-05	0.000187	CcSEcCtD
Atropine—Abdominal pain—Doxorubicin—prostate cancer	8.4e-05	0.000186	CcSEcCtD
Atropine—Body temperature increased—Doxorubicin—prostate cancer	8.4e-05	0.000186	CcSEcCtD
Atropine—Asthenia—Epirubicin—prostate cancer	8.24e-05	0.000182	CcSEcCtD
Atropine—Pruritus—Epirubicin—prostate cancer	8.13e-05	0.00018	CcSEcCtD
Atropine—Diarrhoea—Epirubicin—prostate cancer	7.86e-05	0.000174	CcSEcCtD
Atropine—Hypersensitivity—Doxorubicin—prostate cancer	7.83e-05	0.000173	CcSEcCtD
Atropine—Asthenia—Doxorubicin—prostate cancer	7.63e-05	0.000169	CcSEcCtD
Atropine—Dizziness—Epirubicin—prostate cancer	7.6e-05	0.000168	CcSEcCtD
Atropine—Pruritus—Doxorubicin—prostate cancer	7.52e-05	0.000167	CcSEcCtD
Atropine—Vomiting—Epirubicin—prostate cancer	7.31e-05	0.000162	CcSEcCtD
Atropine—Diarrhoea—Doxorubicin—prostate cancer	7.27e-05	0.000161	CcSEcCtD
Atropine—Rash—Epirubicin—prostate cancer	7.25e-05	0.00016	CcSEcCtD
Atropine—Dermatitis—Epirubicin—prostate cancer	7.24e-05	0.00016	CcSEcCtD
Atropine—Headache—Epirubicin—prostate cancer	7.2e-05	0.000159	CcSEcCtD
Atropine—Dizziness—Doxorubicin—prostate cancer	7.03e-05	0.000156	CcSEcCtD
Atropine—Nausea—Epirubicin—prostate cancer	6.83e-05	0.000151	CcSEcCtD
Atropine—Vomiting—Doxorubicin—prostate cancer	6.76e-05	0.00015	CcSEcCtD
Atropine—Rash—Doxorubicin—prostate cancer	6.7e-05	0.000148	CcSEcCtD
Atropine—Dermatitis—Doxorubicin—prostate cancer	6.7e-05	0.000148	CcSEcCtD
Atropine—Headache—Doxorubicin—prostate cancer	6.66e-05	0.000147	CcSEcCtD
Atropine—Nausea—Doxorubicin—prostate cancer	6.32e-05	0.00014	CcSEcCtD
Atropine—CHRM3—Metabolism—INS—prostate cancer	1.34e-05	6.79e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PIK3CA—prostate cancer	1.33e-05	6.75e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HIF1A—prostate cancer	1.33e-05	6.74e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MDM2—prostate cancer	1.33e-05	6.73e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—LEP—prostate cancer	1.32e-05	6.66e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CREBBP—prostate cancer	1.31e-05	6.65e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—LEP—prostate cancer	1.31e-05	6.64e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ERBB2—prostate cancer	1.31e-05	6.63e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.31e-05	6.61e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CAV1—prostate cancer	1.3e-05	6.6e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CAV1—prostate cancer	1.3e-05	6.58e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—LEP—prostate cancer	1.3e-05	6.58e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CXCL8—prostate cancer	1.3e-05	6.57e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CB—prostate cancer	1.29e-05	6.55e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KDR—prostate cancer	1.29e-05	6.53e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CAV1—prostate cancer	1.29e-05	6.52e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KDR—prostate cancer	1.29e-05	6.51e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.28e-05	6.45e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KDR—prostate cancer	1.27e-05	6.45e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1B—prostate cancer	1.27e-05	6.41e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NQO1—prostate cancer	1.26e-05	6.38e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ESR1—prostate cancer	1.26e-05	6.36e-05	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—AKT1—prostate cancer	1.25e-05	6.35e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ESR1—prostate cancer	1.25e-05	6.34e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CD—prostate cancer	1.25e-05	6.3e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CXCL8—prostate cancer	1.24e-05	6.29e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—TH—prostate cancer	1.24e-05	6.29e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CASP3—prostate cancer	1.24e-05	6.29e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ESR1—prostate cancer	1.24e-05	6.28e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL2—prostate cancer	1.24e-05	6.28e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.23e-05	6.25e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL6—prostate cancer	1.23e-05	6.25e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.23e-05	6.22e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—BAD—prostate cancer	1.23e-05	6.21e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.22e-05	6.19e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—BAD—prostate cancer	1.22e-05	6.19e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1B—prostate cancer	1.21e-05	6.14e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—BAD—prostate cancer	1.21e-05	6.13e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCND1—prostate cancer	1.21e-05	6.12e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.21e-05	6.12e-05	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—AKT1—prostate cancer	1.2e-05	6.08e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CTNNB1—prostate cancer	1.2e-05	6.06e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CASP3—prostate cancer	1.19e-05	6.02e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APC—prostate cancer	1.19e-05	6.01e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	1.19e-05	6.01e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL2—prostate cancer	1.19e-05	6.01e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	1.18e-05	6e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APC—prostate cancer	1.18e-05	6e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL6—prostate cancer	1.18e-05	5.98e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—NOS3—prostate cancer	1.18e-05	5.95e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGF—prostate cancer	1.17e-05	5.95e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IRS1—prostate cancer	1.17e-05	5.95e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MMP9—prostate cancer	1.17e-05	5.94e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APC—prostate cancer	1.17e-05	5.94e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	1.17e-05	5.94e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGF—prostate cancer	1.17e-05	5.93e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IRS1—prostate cancer	1.17e-05	5.93e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GGT1—prostate cancer	1.17e-05	5.93e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1A—prostate cancer	1.17e-05	5.92e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PTEN—prostate cancer	1.17e-05	5.91e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGF—prostate cancer	1.16e-05	5.87e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IRS1—prostate cancer	1.16e-05	5.87e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCND1—prostate cancer	1.16e-05	5.86e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.15e-05	5.84e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CTNNB1—prostate cancer	1.15e-05	5.8e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GSK3B—prostate cancer	1.14e-05	5.77e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—AKT1—prostate cancer	1.14e-05	5.76e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GSK3B—prostate cancer	1.14e-05	5.75e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.14e-05	5.75e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	1.13e-05	5.7e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—INS—prostate cancer	1.12e-05	5.69e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MMP9—prostate cancer	1.12e-05	5.69e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—INS—prostate cancer	1.12e-05	5.68e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1A—prostate cancer	1.12e-05	5.67e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PTEN—prostate cancer	1.12e-05	5.66e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EP300—prostate cancer	1.11e-05	5.63e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—INS—prostate cancer	1.11e-05	5.62e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CREBBP—prostate cancer	1.1e-05	5.58e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CREBBP—prostate cancer	1.1e-05	5.56e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—RXRA—prostate cancer	1.1e-05	5.55e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—AKT1—prostate cancer	1.09e-05	5.52e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF1—prostate cancer	1.09e-05	5.51e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	1.09e-05	5.51e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CB—prostate cancer	1.09e-05	5.49e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF1—prostate cancer	1.08e-05	5.49e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—EGFR—prostate cancer	1.08e-05	5.48e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SRC—prostate cancer	1.08e-05	5.48e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—EGFR—prostate cancer	1.08e-05	5.46e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTGS2—prostate cancer	1.08e-05	5.44e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF1—prostate cancer	1.07e-05	5.44e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	1.07e-05	5.41e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.07e-05	5.4e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EP300—prostate cancer	1.07e-05	5.39e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—COMT—prostate cancer	1.06e-05	5.35e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—prostate cancer	1.05e-05	5.33e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.05e-05	5.32e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	1.05e-05	5.32e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	1.05e-05	5.31e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	1.04e-05	5.29e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—STAT3—prostate cancer	1.04e-05	5.28e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	1.04e-05	5.27e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	1.04e-05	5.25e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SRC—prostate cancer	1.04e-05	5.25e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.03e-05	5.24e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	1.03e-05	5.24e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	1.03e-05	5.23e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	1.03e-05	5.22e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	1.03e-05	5.22e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	1.03e-05	5.21e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—KRAS—prostate cancer	1.02e-05	5.18e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	1.02e-05	5.17e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	1.02e-05	5.16e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—KRAS—prostate cancer	1.02e-05	5.16e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.02e-05	5.15e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	1.01e-05	5.11e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—prostate cancer	1.01e-05	5.11e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FGF2—prostate cancer	1e-05	5.06e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—STAT3—prostate cancer	9.99e-06	5.06e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FGF2—prostate cancer	9.97e-06	5.05e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FGF2—prostate cancer	9.87e-06	5e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOS3—prostate cancer	9.86e-06	4.99e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOS3—prostate cancer	9.83e-06	4.98e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—TYMS—prostate cancer	9.78e-06	4.95e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOS3—prostate cancer	9.74e-06	4.93e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MYC—prostate cancer	9.7e-06	4.91e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TGFB1—prostate cancer	9.67e-06	4.9e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTM1—prostate cancer	9.66e-06	4.89e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—JAK2—prostate cancer	9.59e-06	4.85e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—JAK2—prostate cancer	9.56e-06	4.84e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LPL—prostate cancer	9.49e-06	4.8e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EGFR—prostate cancer	9.48e-06	4.8e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—JAK2—prostate cancer	9.46e-06	4.79e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	9.4e-06	4.76e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTEN—prostate cancer	9.38e-06	4.75e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	9.37e-06	4.74e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MDM2—prostate cancer	9.36e-06	4.74e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MDM2—prostate cancer	9.33e-06	4.72e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MYC—prostate cancer	9.29e-06	4.7e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	9.28e-06	4.69e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TGFB1—prostate cancer	9.26e-06	4.69e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MDM2—prostate cancer	9.24e-06	4.68e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ERBB2—prostate cancer	9.23e-06	4.67e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ERBB2—prostate cancer	9.2e-06	4.66e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP1A1—prostate cancer	9.16e-06	4.64e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	9.11e-06	4.61e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	9.11e-06	4.61e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ERCC2—prostate cancer	9.09e-06	4.6e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EGFR—prostate cancer	9.08e-06	4.6e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	9.08e-06	4.59e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	8.99e-06	4.55e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KRAS—prostate cancer	8.96e-06	4.54e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—EP300—prostate cancer	8.94e-06	4.53e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CXCL8—prostate cancer	8.75e-06	4.43e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CXCL8—prostate cancer	8.72e-06	4.41e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	8.64e-06	4.37e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KRAS—prostate cancer	8.58e-06	4.34e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	8.54e-06	4.33e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—MTHFR—prostate cancer	8.54e-06	4.32e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	8.52e-06	4.31e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	8.45e-06	4.28e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	8.43e-06	4.27e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	8.43e-06	4.26e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARA—prostate cancer	8.38e-06	4.24e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CASP3—prostate cancer	8.37e-06	4.24e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL2—prostate cancer	8.36e-06	4.23e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CASP3—prostate cancer	8.35e-06	4.23e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	8.34e-06	4.22e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL2—prostate cancer	8.34e-06	4.22e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL6—prostate cancer	8.32e-06	4.21e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL6—prostate cancer	8.29e-06	4.2e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CASP3—prostate cancer	8.27e-06	4.18e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL2—prostate cancer	8.25e-06	4.18e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CA—prostate cancer	8.23e-06	4.17e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL6—prostate cancer	8.21e-06	4.16e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCND1—prostate cancer	8.15e-06	4.13e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCND1—prostate cancer	8.13e-06	4.11e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	8.07e-06	4.09e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCND1—prostate cancer	8.05e-06	4.07e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	8.05e-06	4.07e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	7.97e-06	4.03e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TP53—prostate cancer	7.96e-06	4.03e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MMP9—prostate cancer	7.91e-06	4.01e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MMP9—prostate cancer	7.89e-06	3.99e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	7.89e-06	3.99e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CA—prostate cancer	7.88e-06	3.99e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CAV1—prostate cancer	7.88e-06	3.99e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTEN—prostate cancer	7.87e-06	3.98e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	7.86e-06	3.98e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTEN—prostate cancer	7.84e-06	3.97e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MMP9—prostate cancer	7.81e-06	3.95e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	7.78e-06	3.94e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTEN—prostate cancer	7.77e-06	3.93e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	7.68e-06	3.89e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	7.65e-06	3.87e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TP53—prostate cancer	7.63e-06	3.86e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	7.58e-06	3.84e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.53e-06	3.81e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EP300—prostate cancer	7.5e-06	3.8e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EP300—prostate cancer	7.48e-06	3.79e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EP300—prostate cancer	7.41e-06	3.75e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SRC—prostate cancer	7.3e-06	3.69e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL6—prostate cancer	7.29e-06	3.69e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SRC—prostate cancer	7.27e-06	3.68e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SRC—prostate cancer	7.2e-06	3.65e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CG—prostate cancer	7.18e-06	3.63e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	7.11e-06	3.6e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	7.08e-06	3.59e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STAT3—prostate cancer	7.04e-06	3.56e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	7.02e-06	3.55e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STAT3—prostate cancer	7.01e-06	3.55e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL6—prostate cancer	6.98e-06	3.53e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STAT3—prostate cancer	6.95e-06	3.52e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—INS—prostate cancer	6.79e-06	3.44e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT1—prostate cancer	6.72e-06	3.4e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CREBBP—prostate cancer	6.65e-06	3.37e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CA—prostate cancer	6.62e-06	3.35e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MYC—prostate cancer	6.54e-06	3.31e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	6.52e-06	3.3e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MYC—prostate cancer	6.52e-06	3.3e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	6.5e-06	3.29e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MYC—prostate cancer	6.45e-06	3.27e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT1—prostate cancer	6.44e-06	3.26e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	6.44e-06	3.26e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGFR—prostate cancer	6.4e-06	3.24e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGFR—prostate cancer	6.37e-06	3.23e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGFR—prostate cancer	6.31e-06	3.2e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CD—prostate cancer	6.31e-06	3.19e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KRAS—prostate cancer	6.04e-06	3.06e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KRAS—prostate cancer	6.02e-06	3.05e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KRAS—prostate cancer	5.96e-06	3.02e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NOS3—prostate cancer	5.96e-06	3.02e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	5.55e-06	2.81e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	5.53e-06	2.8e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CB—prostate cancer	5.5e-06	2.78e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	5.48e-06	2.77e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS2—prostate cancer	5.45e-06	2.76e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AKT1—prostate cancer	5.41e-06	2.74e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TP53—prostate cancer	5.37e-06	2.72e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TP53—prostate cancer	5.35e-06	2.71e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TP53—prostate cancer	5.3e-06	2.68e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6—prostate cancer	4.92e-06	2.49e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6—prostate cancer	4.9e-06	2.48e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6—prostate cancer	4.85e-06	2.46e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTEN—prostate cancer	4.75e-06	2.4e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT1—prostate cancer	4.53e-06	2.3e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—EP300—prostate cancer	4.53e-06	2.29e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT1—prostate cancer	4.52e-06	2.29e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT1—prostate cancer	4.48e-06	2.27e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CA—prostate cancer	3.35e-06	1.7e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKT1—prostate cancer	2.74e-06	1.39e-05	CbGpPWpGaD
